These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11595290)

  • 101. Enhanced cellular immunity in macaques following a novel peptide immunotherapy.
    Chea S; Dale CJ; De Rose R; Ramshaw IA; Kent SJ
    J Virol; 2005 Mar; 79(6):3748-57. PubMed ID: 15731268
    [TBL] [Abstract][Full Text] [Related]  

  • 102. A noninfectious simian/human immunodeficiency virus DNA vaccine that protects macaques against AIDS.
    Singh DK; Liu Z; Sheffer D; Mackay GA; Smith M; Dhillon S; Hegde R; Jia F; Adany I; Narayan O
    J Virol; 2005 Mar; 79(6):3419-28. PubMed ID: 15731236
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Novel adeno-associated virus vector vaccine restricts replication of simian immunodeficiency virus in macaques.
    Johnson PR; Schnepp BC; Connell MJ; Rohne D; Robinson S; Krivulka GR; Lord CI; Zinn R; Montefiori DC; Letvin NL; Clark KR
    J Virol; 2005 Jan; 79(2):955-65. PubMed ID: 15613324
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Immunogenicity study of glycoprotein-deficient rabies virus expressing simian/human immunodeficiency virus SHIV89.6P envelope in a rhesus macaque.
    McKenna PM; Aye PP; Dietzschold B; Montefiori DC; Martin LN; Marx PA; Pomerantz RJ; Lackner A; Schnell MJ
    J Virol; 2004 Dec; 78(24):13455-9. PubMed ID: 15564456
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Repeated low-dose mucosal simian immunodeficiency virus SIVmac239 challenge results in the same viral and immunological kinetics as high-dose challenge: a model for the evaluation of vaccine efficacy in nonhuman primates.
    McDermott AB; Mitchen J; Piaskowski S; De Souza I; Yant LJ; Stephany J; Furlott J; Watkins DI
    J Virol; 2004 Mar; 78(6):3140-4. PubMed ID: 14990733
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Functional human immunodeficiency virus type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and env expressed from a single rhabdovirus-based vaccine vector genome.
    McGettigan JP; Naper K; Orenstein J; Koser M; McKenna PM; Schnell MJ
    J Virol; 2003 Oct; 77(20):10889-99. PubMed ID: 14512539
    [TBL] [Abstract][Full Text] [Related]  

  • 107. The search for an HIV vaccine.
    Makgoba MW; Solomon N; Tucker TJ
    BMJ; 2002 Jan; 324(7331):211-3. PubMed ID: 11809644
    [No Abstract]   [Full Text] [Related]  

  • 108. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination.
    Barouch DH; Santra S; Schmitz JE; Kuroda MJ; Fu TM; Wagner W; Bilska M; Craiu A; Zheng XX; Krivulka GR; Beaudry K; Lifton MA; Nickerson CE; Trigona WL; Punt K; Freed DC; Guan L; Dubey S; Casimiro D; Simon A; Davies ME; Chastain M; Strom TB; Gelman RS; Montefiori DC; Lewis MG; Emini EA; Shiver JW; Letvin NL
    Science; 2000 Oct; 290(5491):486-92. PubMed ID: 11039923
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.
    Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ
    Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Control of simian/human immunodeficiency virus viremia and disease progression after IL-2-augmented DNA-modified vaccinia virus Ankara nasal vaccination in nonhuman primates.
    Bertley FM; Kozlowski PA; Wang SW; Chappelle J; Patel J; Sonuyi O; Mazzara G; Montefiori D; Carville A; Mansfield KG; Aldovini A
    J Immunol; 2004 Mar; 172(6):3745-57. PubMed ID: 15004179
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination.
    Barouch DH; Santra S; Kuroda MJ; Schmitz JE; Plishka R; Buckler-White A; Gaitan AE; Zin R; Nam JH; Wyatt LS; Lifton MA; Nickerson CE; Moss B; Montefiori DC; Hirsch VM; Letvin NL
    J Virol; 2001 Jun; 75(11):5151-8. PubMed ID: 11333896
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Vaccine-elicited immune responses prevent clinical AIDS in SHIV(89.6P)-infected rhesus monkeys.
    Barouch DH; Fu TM; Montefiori DC; Lewis MG; Shiver JW; Letvin NL
    Immunol Lett; 2001 Nov; 79(1-2):57-61. PubMed ID: 11595290
    [TBL] [Abstract][Full Text] [Related]  

  • 113. The critical role of CD4(+) T-cell help in immunity to HIV.
    Heeney JL
    Vaccine; 2002 May; 20(15):1961-3. PubMed ID: 11983254
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Macaque models for AIDS vaccine development.
    Johnson RP
    Curr Opin Immunol; 1996 Aug; 8(4):554-60. PubMed ID: 8794019
    [TBL] [Abstract][Full Text] [Related]  

  • 115.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 116.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.